
Hopia offers an optimized medical and paramedical planning solution for healthcare facilities, leveraging artificial intelligence to automate and simplify the creation and management of staff schedules. The platform aims to free up valuable time for healthcare professionals, allowing them to focus on patient care. It features an intuitive, online interface that is collaborative and automated, significantly reducing the time spent on schedule management (up to 95% reduction). Hopia is also developing AI-driven modules for predicting patient flow to better manage hospital resources, especially during health crises. Their mission is to improve the quality of life and work for healthcare staff and enhance patient care through efficient resource allocation.

Hopia offers an optimized medical and paramedical planning solution for healthcare facilities, leveraging artificial intelligence to automate and simplify the creation and management of staff schedules. The platform aims to free up valuable time for healthcare professionals, allowing them to focus on patient care. It features an intuitive, online interface that is collaborative and automated, significantly reducing the time spent on schedule management (up to 95% reduction). Hopia is also developing AI-driven modules for predicting patient flow to better manage hospital resources, especially during health crises. Their mission is to improve the quality of life and work for healthcare staff and enhance patient care through efficient resource allocation.
What they do: AI-driven online scheduling and resource-optimization platform for medical and paramedical staff
Founded / location: French healthtech (PLANINNOVIA SAS) headquartered in the Paris region
Founders / leadership: Matthias Lesage and Victoire Bach
Employees: 34
Latest funding: Seed: €3.5M (announced Jan 28, 2025)
Healthcare workforce scheduling and hospital resource optimization
Healthtech / Healthcare software
€3,500,000
“Seed round co-led by IRIS and Kurma Partners; participation from multiple angel and VC investors”